Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy.
作者信息
Kozlowski Lynn T
出版信息
Tob Control. 2017 Mar;26(e1):e31-e34. doi: 10.1136/tobaccocontrol-2016-052995. Epub 2016 Jun 29.
Abstract
摘要
相似文献
1
Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy.
Tob Control. 2017 Mar;26(e1):e31-e34. doi: 10.1136/tobaccocontrol-2016-052995. Epub 2016 Jun 29.
2
The case for the WHO Advisory Note, Global Nicotine Reduction Strategy.
Tob Control. 2017 Mar;26(e1):e29-e30. doi: 10.1136/tobaccocontrol-2016-053134. Epub 2016 Jun 29.
3
[European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and "harm reduction"].
Pneumologie. 2024 Jul;78(7):446-452. doi: 10.1055/a-2298-8015. Epub 2024 Apr 26.
4
Managing nicotine without smoke to save lives now: Evidence for harm minimization.
Prev Med. 2018 Dec;117:88-97. doi: 10.1016/j.ypmed.2018.06.010. Epub 2018 Jun 23.
5
Tobacco harm reduction: the need for new products that can compete with cigarettes.
Addict Behav. 2014 Mar;39(3):507-11. doi: 10.1016/j.addbeh.2013.11.002. Epub 2013 Nov 10.
6
Nicotine addiction, reduction, and smoking cessation.
Lancet. 2017 Aug 19;390(10096):716. doi: 10.1016/S0140-6736(17)32240-7.
7
FDA's new plan to reduce the nicotine in cigarettes to sub-addictive levels could be a game-changer.
Tob Control. 2016 Sep;26(5):487-488. doi: 10.1136/tobaccocontrol-2017-053978.
8
[Harm reduction strategy in tobacco control].
Epidemiol Prev. 2011 May-Aug;35(3-4 Suppl 1):19-32.
9
Tobacco, nicotine and harm reduction.
Drug Alcohol Rev. 2011 Mar;30(2):119-23. doi: 10.1111/j.1465-3362.2010.00264.x.
10
Let actual markets help assess the worth of optional very-low-nicotine cigarettes before deciding on mandatory regulations.
Addiction. 2017 Jan;112(1):3-5. doi: 10.1111/add.13515. Epub 2016 Aug 23.
引用本文的文献
1
The Agronomic Traits, Alkaloids Analysis, FT-IR and 2DCOS-IR Spectroscopy Identification of the Low-Nicotine-Content Nontransgenic Tobacco Edited by CRISPR-Cas9.
Molecules. 2022 Jun 14;27(12):3817. doi: 10.3390/molecules27123817.
2
A review of the evidence on cigarettes with reduced addictiveness potential.
Int J Drug Policy. 2022 Jan;99:103436. doi: 10.1016/j.drugpo.2021.103436. Epub 2021 Sep 15.
3
"I actually finally feel like the cigarettes aren't controlling me." - Interviews with participants smoking very low nicotine content cigarettes during a residential study.
Drug Alcohol Depend. 2021 Feb 1;219:108465. doi: 10.1016/j.drugalcdep.2020.108465. Epub 2020 Dec 19.
4
Nicotine reduction does not alter essential value of nicotine or reduce cue-induced reinstatement of nicotine seeking.
Drug Alcohol Depend. 2020 Jul 1;212:108020. doi: 10.1016/j.drugalcdep.2020.108020. Epub 2020 Apr 25.
5
A Novel Method for Evaluating the Acceptability of Substitutes for Cigarettes: The Experimental Tobacco Marketplace.
Tob Regul Sci. 2017 Jul;3(3):266-279. doi: 10.18001/TRS.3.3.3.
6
Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.
Am J Public Health. 2019 Jul;109(7):1007-1014. doi: 10.2105/AJPH.2019.305067.
7
Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.
Tob Control. 2019 May;28(3):352-355. doi: 10.1136/tobaccocontrol-2018-054622. Epub 2018 Nov 1.
8
Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial.
Nicotine Tob Res. 2019 Jun 21;21(7):962-969. doi: 10.1093/ntr/nty079.
9
Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.
Prev Med. 2018 Dec;117:8-14. doi: 10.1016/j.ypmed.2018.03.021. Epub 2018 Mar 29.
10
Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands.
Nicotine Tob Res. 2019 May 21;21(6):784-791. doi: 10.1093/ntr/nty042.
本文引用的文献
1
Randomized Trial of Reduced-Nicotine Standards for Cigarettes.
N Engl J Med. 2015 Oct;373(14):1340-9. doi: 10.1056/NEJMsa1502403.
2
Coping with the Conflict-of-Interest Pandemic by Listening to and Doubting Everyone, Including Yourself.
Sci Eng Ethics. 2016 Apr;22(2):591-6. doi: 10.1007/s11948-015-9658-9. Epub 2015 May 30.
3
Prospects for a nicotine-reduction strategy in the cigarette endgame: Alternative tobacco harm reduction scenarios.
Int J Drug Policy. 2015 Jun;26(6):543-7. doi: 10.1016/j.drugpo.2015.02.001. Epub 2015 Feb 23.
4
Cannabis legalization with strict regulation, the overall superior policy option for public health.
Clin Pharmacol Ther. 2015 Jun;97(6):541-4. doi: 10.1002/cpt.93. Epub 2015 May 2.
5
How has the availability of snus influenced cigarette smoking in Norway?
Int J Environ Res Public Health. 2014 Nov 13;11(11):11705-17. doi: 10.3390/ijerph111111705.
6
Cigarette smoking and mental illness: a study of nicotine withdrawal.
Am J Public Health. 2014 Feb;104(2):e127-33. doi: 10.2105/AJPH.2013.301502. Epub 2013 Dec 12.
7
Reducing the nicotine content to make cigarettes less addictive.
Tob Control. 2013 May;22 Suppl 1(Suppl 1):i14-7. doi: 10.1136/tobaccocontrol-2012-050860.
8
Nicotine reduction: strategic research plan.
Nicotine Tob Res. 2013 Jun;15(6):1003-13. doi: 10.1093/ntr/nts214. Epub 2012 Oct 25.
9
Research required for the effective implementation of the framework convention on tobacco control, articles 9 and 10.
Nicotine Tob Res. 2013 Apr;15(4):777-88. doi: 10.1093/ntr/nts175. Epub 2012 Sep 27.
10
The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
Nicotine Tob Res. 2012 Dec;14(12):1467-73. doi: 10.1093/ntr/nts018. Epub 2012 Mar 30.
Zotero 插件